Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 100: 1753-1754, 2006; doi:10.1152/japplphysiol.00190.2005
8750-7587/06 $8.00
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reid, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reid, M. B.

INVITED EDITORIAL

Waste not, weak not?

Michael B. Reid

Department of Physiology
University of Kentucky
Lexington, Kentucky
e-mail: michael.reid{at}uky.edu

When we catch a cold or the flu, most of us experience a sensation of "tiredness" or "weakness" that makes it difficult to go about our daily tasks. Weakness is a common symptom of infectious processes. A Medline search that cross-references "infection" and "weakness" yields over 1,900 references. This extensive literature documents muscular weakness in processes that range from food poisoning (2) to malaria (4) to intrauterine fungal infection (11). Weakness is especially common in individuals with blood-borne infections, termed sepsis, and can affect the muscles of respiration (7). This poses serious consequences for health. Respiratory muscle weakness predisposes septic individuals to respiratory insufficiency and dependence on a mechanical ventilator, increasing the risk of complications and prolonging hospitalization.

The mechanisms by which infections cause muscle weakness remain poorly understood. Apart from conditions that affect the nervous system or neuromuscular transmission, muscle weakness is generally attributed to loss of muscle mass (6). Inflammatory mediators can stimulate muscle catabolism by accelerating protein degradation (1). Therefore, the general model is that infection stimulates inflammation that leads to muscle wasting and thereby weakness (see Fig. 1).


Figure 1
View larger version (56K):
[in this window]
[in a new window]
 
Fig. 1. Model of infection-induced muscle weakness. Infection increases circulating levels of inflammatory mediators, e.g., endotoxin, cytokines, and chemokines. These act on muscle cells to stimulate production of reactive oxygen species (ROS), nitric oxide (NO) derivatives, proteases, and other autocrine mediators that influence force production via two parallel mechanisms: 1) changes in myofilament function or calcium regulation can cause contractile dysfunction, decreasing force/cross-sectional area and 2) upregulation of calpains and regulatory proteins in the ubiquitin-proteasome pathway promote protein degradation, decreasing muscle mass. These 2 mechanisms have additive effects on muscle force; increases in either will promote weakness.

 
But this model does not always apply. Force decrements are not universally explained by muscle atrophy (3, 5, 8, 10). In the early stages of infection, for example, weakness may precede overt loss of protein such that existing muscle generates less-than-normal force (2, 4, 11). This suggests that infection or the associated inflammatory response can cause contractile dysfunction, leading to weakness without wasting.

In this issue of the Journal of Applied Physiology, Supinski and Callahan (9) elegantly demonstrate muscle weakness without wasting in an experimental model of sepsis. The investigators injected mice with endotoxin, a lipopolysaccharide derived from bacterial cell walls, and documented profound loss of contractile function in the diaphragm. This weakness was not associated with diaphragm atrophy. Neither muscle weight nor protein content was changed. Rather, weakness was wholly attributable to a decrement in force per cross-sectional area, which fell by one-half, and was linked to a rise in caspase 3 activity. Pharmacologic caspase blockade completely abolished the muscle weakness caused by endotoxin, establishing a causal relationship.

These observations are the first to demonstrate that caspase activity contributes to the weakness caused by infection. Two previous reports have associated caspase activity with myocyte apoptosis (12, 13), suggesting a role in muscle atrophy, but caspase-induced contractile dysfunction has never been proposed in skeletal muscle. This discovery triggers a flurry of subsequent questions. For example, what causes caspase activation in muscle? What is the molecular target of caspase action that causes contractile dysfunction? Do caspases mediate weakness in other conditions that diminish force per cross-sectional area, e.g., sarcopenia of aging (3), prolonged bed rest (10), cardiac cachexia (5), and cytokine stimulation (8)?

Supinski and Callahan (9) have also identified a novel target for drug development. There is no pharmacologic intervention for the diaphragm weakness that develops during sepsis, no drug to treat the ventilatory failure that commonly occurs in these individuals. If caspase inhibitors protect diaphragm function in septic humans, such drugs would be of enormous clinical benefit in the management of critically ill patients. Clearly, the current report by Supinski and Callahan will be of interest to researchers and clinicians alike.

REFERENCES

  1. Chang HR and Bistrian B. The role of cytokines in the catabolic consequences of infection and injury. J Parenter Enteral Nutr 22: 156–166, 1998.[Abstract]
  2. Claesson BE, Svensson NG, Gotthardsson L, and Garden B. A foodborne outbreak of group A streptococcal disease at a birthday party. Scand J Infect Dis 24: 577–586, 1992.[ISI][Medline]
  3. Frontera WR, Hughes VA, Krivickas LS, Kim SK, Foldvari M, and Roubenoff R. Strength training in older women: early and late changes in whole muscle and single cells. Muscle Nerve 28: 601–608, 2003.[CrossRef][ISI][Medline]
  4. Grobusch MP and Krensner PG. Uncomplicated malaria. Curr Top Microbiol Immunol 295: 83–104, 2005.[ISI][Medline]
  5. Harrington D, Anker SD, Chua TP, Webb-Peploe KM, Ponikowski PP, Poole-Wilson PA, and Coats AJ. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 30: 1758–1764, 1997.[Abstract]
  6. Hund E. Neurological complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol 248: 929–934, 2001.[CrossRef][ISI][Medline]
  7. Hussain SN. Respiratory muscle dysfunction in sepsis. Mol Cell Biochem 179: 125–134, 1998.[CrossRef][ISI][Medline]
  8. Li X, Moody MR, Engel D, Walker S, Clubb FJ, Sivasubramanian N, Mann DL, and Reid MB. Cardiac-specific overexpression of TNF-{alpha} causes oxidative stress and contractile dysfunction in mouse diaphragm. Circulation 102: 1690–1696, 2000.[Abstract/Free Full Text]
  9. Supinski GS and Callahan LA. Caspase activation contributes to endotoxin-induced diaphragm weakness. J Appl Physiol 100: 1770–1777, 2006[Abstract/Free Full Text]
  10. Trappe S, Trappe T, Gallagher P, Harber M, Alkner B, and Tesch P. Human single muscle fibre function with 84 day bed-rest and resistance exercise. J Physiol 557: 501–513, 2004.[Abstract/Free Full Text]
  11. Wagner M, Kiselow MC, Goodman JJ, Biever P, and Gill L. The relationship of the intrauterine device, actinomycosis infection, and bowel abscesses. Wis Med J 78: 23–26, 1979.[ISI][Medline]
  12. Yan JS, Ramanathan MP, Muthumani K, Choo AY, Jin SH, Yu QC, Hwang DS, Choo DK, Lee MD, Dang K, Tang W, Kim JJ, and Weiner DB. Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway. Emerg Infect Dis 9: 406–409, 2003.
  13. Yasuhara S, Perez ME, Kanakubo E, Yasuhara Y, Shin YS, Kaneki M, Fujita T, and Martyn JA. Skeletal muscle apoptosis after burns is associated with activation of proapoptotic signals. Am J Physiol Endocrinol Metab 279: E1114–E1121, 2000.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
G. S. Supinski, X. Ji, W. Wang, and L. A. Callahan
The extrinsic caspase pathway modulates endotoxin-induced diaphragm contractile dysfunction
J Appl Physiol, April 1, 2007; 102(4): 1649 - 1657.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reid, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reid, M. B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.